Literature DB >> 31049703

Administration of memantine reverses behavioral, histological, and electrophysiological abnormalities in rats subjected to early maternal deprivation.

Ezequiel Uribe1,2, Leticia Fernández3, Dulce Pacheco3, Luis Fernandez3, Nieves Nayadoleni3, Antonio Eblen-Zajjur3,4,5.   

Abstract

Schizophrenia (SCZ) is a severe and chronic neurodevelopmental disorder with onset occurring during adolescence or early adulthood; notwithstanding, the brain dysfunction occurs before the disease and is not clinically evident. Recently, memantine (MEM) had been postulated as an effective preventive treatment in rats. In this study, was performed the Early Maternal Deprivation (EMD) protocol in Sprague-Dawley rats, establishing four groups (control, EMD, EMD treated with MEM, and MEM treatment). Behavioral parameters such as active linking (AL) and T maze were evaluated as well as quantitative brain histological changes at 3, 7, and 10 weeks of age, to understand the longitudinal demeanor of the disease. Prefrontal evoked potentials (PFEPs) were recorded to study functional synaptic connectivity and neuronal synchronicity changes. The results showed that EMD induces a decrease of AL and poor performance of T maze, in addition to volumetric changes of cortical and subcortical brain structures and abnormalities in PFEPs. The majority of this changes were absent by neonatal MEM administration. Taking into account that all these abnormalities are associated to SCZ, we propose to MEM as a potential preventive treatment.

Entities:  

Keywords:  Hippocampus; Maternal deprivation; Memantine; Prefrontal cortex; Primary auditory cortex; Schizophrenia; Social cognition; Striatum

Year:  2019        PMID: 31049703     DOI: 10.1007/s00702-019-02007-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

Review 1.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

Review 2.  Neurobiology of schizophrenia.

Authors:  Christopher A Ross; Russell L Margolis; Sarah A J Reading; Mikhail Pletnikov; Joseph T Coyle
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

3.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  Activity-dependent structural plasticity.

Authors:  Markus Butz; Florentin Wörgötter; Arjen van Ooyen
Journal:  Brain Res Rev       Date:  2009-01-06

5.  Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement.

Authors:  Gina Turrigiano
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

6.  Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis.

Authors:  A Becker; G Grecksch; H G Bernstein; V Höllt; B Bogerts
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

7.  Neuroprotective effect of memantine on hippocampal neurons in infantile rat hydrocephalus.

Authors:  Burak Cabuk; Volkan Etus; Suheyla Uyar Bozkurt; Aydin Sav; Savas Ceylan
Journal:  Turk Neurosurg       Date:  2011       Impact factor: 1.003

Review 8.  Understanding and treating "first-episode" schizophrenia.

Authors:  Peter J Weiden; Peter F Buckley; Michael Grody
Journal:  Psychiatr Clin North Am       Date:  2007-09

9.  Assessment of social interaction behaviors.

Authors:  Oksana Kaidanovich-Beilin; Tatiana Lipina; Igor Vukobradovic; John Roder; James R Woodgett
Journal:  J Vis Exp       Date:  2011-02-25       Impact factor: 1.355

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.